Citius Oncology reports 120% jump in LYMPHIR wholesaler unit sales for fiscal Q4 2026
Preliminary, unaudited figures show 792 units sold to U.S. wholesalers in the quarter ended September 30, 2026, up from 360 in the prior quarter, with institutional adoption also rising.
SEC filing (2)